Summary:
Phase III study evaluating a new narcotic pain medication and its ability to reduce chronic pain.
Qualified Participants Must:
• Be over 21 years of age
•
Have diagnosed chronic pain
•
Be willing to follow all terms of the study protocol
Qualified Participants May Receive:
Study medication and study-related medical care at no cost.